Gold Nanoparticle Conjugates and Uses Thereof

US2016017065A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016017065-A1
Application numberUS-201514867165-A
CountryUS
Kind codeA1
Filing dateSep 28, 2015
Priority dateAug 22, 2007
Publication dateJan 21, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The disclosure generally relates to formation of polymers grafted to or polymerized from the surface of gold nanoparticles. The polymers are functionalized to include therapeutic agents and/or targeting agents at their surface, thereby allowing both therapeutic and targeting compounds to be directed to specific cells in a patient.

First claim

Opening claim text (preview).

What is claimed is: 1 . A method of making a gold nanoparticle conjugate comprising: contacting a trithiocarbonate of the following formula with an alkene of the following formula to produce a polymer of the following formula and contacting the polymer with a gold nanoparticle to form the gold nanoparticle conjugate, wherein R 1 , R 2 , R 3 , and R 4 are each independently selected from hydrogen, alkyl, substituted alkyl, alkoxy, substituted alkoxy, acyl, substituted acyl, acylamino, substituted acylamino, alkylamino, substituted alkylamino, alkylsulfinyl, substituted alkylsulfinyl, alkylsulfonyl, substituted alkylsulfonyl, alkylthio, substituted alkylthio, alkoxycarbonyl, substituted alkoxycarbonyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, aryloxy, substituted aryloxy, aryloxycarbonyl, substituted aryloxycarbonyl, carbamoyl, substituted carbamoyl, cycloalkyl, substituted cycloalkyl, cycloheteroalkyl, substituted cycloheteroalkyl, dialkylamino, substituted dialkylamino, halo, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl, substituted heteroarylalkyl, heteroalkyloxy, substituted heteroalkyloxy, heteroaryloxy and substituted heteroaryloxy. 2 . The method of claim 1 , wherein the gold nanoparticle conjugate has the following formula represents the surface of the gold nanoparticle. 3 . The method of claim 1 , wherein the trithiocarbonate and alkene are contacted under non-reducing conditions. 4 . The method of claim 1 , wherein the polymer and gold nanoparticle are contacted under non-reducing conditions. 5 . The method of claim 1 , wherein the polymer and gold nanoparticle are associated through more than one sulfur atom. 6 . The method of claim 1 , wherein the gold nanoparticle conjugate further comprises a functional group. 7 . The method of claim 6 , wherein the functional group is selected from the group consisting of carboxylic acids and carboxylic acid salt derivatives, acid halides, sulfonic acids and sulfonic acid salts, anhydride derivatives, hydroxyl derivatives, amine and amide derivatives, silane derivations, phosphate derivatives, nitro derivatives, succinimide and sulfo-containing succinimide derivatives, halide derivatives, alkene derivatives, morpholine derivatives, cyano derivatives, epoxide derivatives, ester derivatives, carbazole derivatives, azide derivatives, alkyne derivatives, acid containing sugar derivatives, glycerol analogue derivatives, maleimide derivatives, protected acids and alcohols, and acid halide derivatives. 8 . The method of claim 1 , wherein the gold nanoparticle conjugate further comprises a therapeutic agent covalently bonded to the polymer. 9 . The method of claim 1 , wherein the gold nanoparticle conjugate further comprises a targeting agent covalently bonded to the polymer. 10 . A method of making a gold nanoparticle conjugate comprising: contacting a compound of the following formula with an alkene of the following formula to produce a polymer of the following formula and contacting the polymer with a gold nanoparticle to form the gold nanoparticle conjugate, wherein R 1 , R 2 , R 3 , and R 4 are each independently selected from hydrogen, alkyl, substituted alkyl, alkoxy, substituted alkoxy, acyl, substituted acyl, acylamino, substituted acylamino, alkylamino, substituted alkylamino, alkylsulfinyl, substituted alkylsulfinyl, alkylsulfonyl, substituted alkylsulfonyl, alkylthio, substituted alkylthio, alkoxycarbonyl, substituted alkoxycarbonyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, aryloxy, substituted aryloxy, aryloxycarbonyl, substituted aryloxycarbonyl, carbamoyl, substituted carbamoyl, cycloalkyl, substituted cycloalkyl, cycloheteroalkyl, substituted cycloheteroalkyl, dialkylamino, substituted dialkylamino, halo, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl, substituted heteroarylalkyl, heteroalkyloxy, substituted heteroalkyloxy, heteroaryloxy and substituted heteroaryloxy. 11 . The method of claim 10 , wherein the compound is a dithioester, xanthate, or dithiocarbamate. 12 . The method of claim 10 , wherein the gold nanoparticle conjugate has the following formula represents the surface of the gold nanoparticle. 13 . The method of claim 10 , wherein the compound and alkene are contacted under non-reducing conditions. 14 . The method of claim 10 , wherein the polymer and gold nanoparticle are contacted under non-reducing conditions. 15 . The method of claim 10 , wherein the polymer and gold nanoparticle are associated through more than one sulfur atom. 16 . The method of claim 10 , wherein the gold nanoparticle conjugate further comprises a functional group. 17 . The method of claim 16 , wherein the functional group is selected from the group consisting of carboxylic acids and carboxylic acid salt derivatives, acid halides, sulfonic acids and sulfonic acid salts, anhydride derivatives, hydroxyl derivatives, amine and amide derivatives, silane derivations, phosphate derivatives, nitro derivatives, succinimide and sulfo-containing succinimide derivatives, halide derivatives, alkene derivatives, morpholine derivatives, cyano derivatives, epoxide derivatives, ester derivatives, carbazole derivatives, azide derivatives, alkyne derivatives, acid containing sugar derivatives, glycerol analogue derivatives, maleimide derivatives, protected acids and alcohols, and acid halide derivatives. 18 . The method of claim 10 , wherein the gold nanoparticle conjugate further comprises a therapeutic agent covalently bonded to said polymer. 19 . The method of claim 10 , wherein the gold nanoparticle conjugate further comprises a targeting agent covalently bonded to said polymer.

Assignees

Inventors

Classifications

  • particles, e.g. uncoated or non-functionalised microparticles or nanoparticles · CPC title

  • obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin · CPC title

  • Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery · CPC title

  • Antineoplastic agents · CPC title

  • Macromolecular compounds, i.e. oligomers, polymers, dendrimers · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016017065A1 cover?
The disclosure generally relates to formation of polymers grafted to or polymerized from the surface of gold nanoparticles. The polymers are functionalized to include therapeutic agents and/or targeting agents at their surface, thereby allowing both therapeutic and targeting compounds to be directed to specific cells in a patient.
Who is the assignee on this patent?
Colorado School Of Mines
What technology area does this patent fall under?
Primary CPC classification C08F8/42. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Jan 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).